The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

Metan G., Agkus C., Buldu H., KOÇ A. N.

INFECTION, vol.38, no.3, pp.217-221, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 3
  • Publication Date: 2010
  • Doi Number: 10.1007/s15010-010-0003-6
  • Journal Name: INFECTION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.217-221
  • Keywords: Aspergillus galactomannan antigen, 1,3-Beta-D-glucan, False positivity, Piperacillin/tazobactam, HEMATOLOGICAL MALIGNANCIES, ENZYME-IMMUNOASSAY, TAZOBACTAM, DIAGNOSIS, PROPHYLAXIS, ANTIGENEMIA, KINETICS
  • Hacettepe University Affiliated: No


The aim of this study was to investigate the interaction between intravenous piperacillin/tazobactam treatment and Aspergillus galactomannan antigen (GM) and 1,3-beta-d-glucan (BDG) test results in patients without known risk factors for invasive fungal infections (IFI).